logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

BEKE-W (02423) invested 4,273,500 US dollars to repurchase 802,400 shares on April 29th.

date
19:52 30/04/2026
avatar
GMT Eight
Shell Group-W (02423) announced that on April 29, 2026, the company spent 4.2735 million US dollars to repurchase 802,400 shares at a repurchase price of $5.27-$5.44 per share.
BEKE-W (02423) announced that the company will spend $4.2735 million to repurchase 802,400 shares on April 29, 2026, at a repurchase price of $5.27-5.44 per share.
Related Articles
HK Stock
VANOV HOLDINGS (02260): Jiang Zhaozhe appointed as independent non-executive director.
HK Stock
LIANLIAN (02598) spent 1.5245 million Hong Kong dollars to repurchase 267,000 shares on April 30.
US Stock
Merck & Co., Inc. (MRK.US) narrows full-year guidance, strong demand for new drugs drives Q1 revenue beyond expectations.
VANOV HOLDINGS (02260): Jiang Zhaozhe appointed as independent non-executive director.
HK Stock
LIANLIAN (02598) spent 1.5245 million Hong Kong dollars to repurchase 267,000 shares on April 30.
HK Stock
Merck & Co., Inc. (MRK.US) narrows full-year guidance, strong demand for new drugs drives Q1 revenue beyond expectations.
US Stock
RECOMMEND
China Leads as Humanoid Robotics Reach Commercial Turning Point
China Leads as Humanoid Robotics Reach Commercial Turning Point
icon
29/04/2026
AI Disruption Reshapes US Equity Valuations as Terminal Value Volatility Takes Center Stage
AI Disruption Reshapes US Equity Valuations as Terminal Value Volatility Takes Center Stage
icon
29/04/2026
Political Bureau Meeting Sets Tone for Growth Eight Key Takeaways on Property Capital Markets and Monetary Policy
Political Bureau Meeting Sets Tone for Growth Eight Key Takeaways on Property Capital Markets and Monetary Policy
icon
29/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.